Coya Therapeutics Inc —— 季度财务数据 (NASDAQ:COYA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -2.41 M-2.83 M-5.77 M-1.13 M-1.01 M -10.74 M 投资活动产生的现金 0-25 K00-648.61 K — 融资活动产生的现金 9.69 M19.14 K019.14 K20.35 M 20.39 M 自由现金流 -2.41 M-2.83 M-5.77 M-1.13 M-1.01 M -10.74 M

新闻

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com

Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?

H.C. Wainwright 维持Coya Therapeutics股票买入评级，目标价18美元

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target

Coya Therapeutics完成1110万美元私募融资

Coya Therapeutics secures $11.1 million in private placement

Coya Therapeutics推进ALS和FTD临床试验至2026年

Coya Therapeutics advances ALS and FTD clinical trials in 2026

H.C. Wainwright维持Coya Therapeutics股票18美元的买入评级

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18

Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)

H.C. Wainwright重申Coya Therapeutics股票买入评级